中国医学创新Issue(23)：15-16,2.DOI:10.3969/j.issn.1674-4985.2013.23.007
齐拉西酮与奥氮平治疗女性精神分裂症的对照研究*
A Comparative Study of Ziprasidone and Olanzapine in the Treatment of Female Schizophrenia
摘要
Abstract
Objective:To compare the clinical efficacy and safety of ziprasidone and olanzapine in the treatment of female schizophenia. Method:80 cases with female schizophrenia were divided randomly into two groups by single blind contrast.Each group with 40 cases,compare the use of ziprasidone and olanzapine in the treatment for 8 weeks.Positive and Negative syndrome scale(PANSS)was used to assess the efficacy,side effects scale(TESS)was used to assess adverse reactions.Result:There was significant curative effect of two groups.But the ziprasidone group cause less adverse reactions than the olanzapine group,with no significant effect on weight of patients,not easy to cause sleepiness.Conclusion:Ziprasidone is an effective and safe antipsychotic drug,more suitable for treatment of female patients with schizophrenia.关键词
齐拉西酮/奥氮平/女性/精神分裂症Key words
Ziprasidone/Olanzapine/Female/Schizophrenia引用本文复制引用
付春红,余绍军,曹青,鲍观兴..齐拉西酮与奥氮平治疗女性精神分裂症的对照研究*[J].中国医学创新,2013,(23):15-16,2.基金项目
2012年江西省宜春市课题 （）
